Finance

Beta
Lists
CSTL:NASDAQ
Castle Biosciences Inc
$23.95
+4.54%
(+1.04) 1D
Jun 26, 1:34:33 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CSTL...
Open
$22.67
High
$24.29
Low
$22.67
Mkt. cap
726.40M
Avg. vol.
389.19K
Volume
241.66K
52-wk high
$44.28
52-wk low
$14.59
EPS
-$0.43
Beta
1.04
Shares outstanding
30.33M
No. of employees
942
Open
$22.67
High
$24.29
Low
$22.67
Mkt. cap
726.40M
Avg. vol.
389.19K
Volume
241.66K
52-wk high
$44.28
52-wk low
$14.59
EPS
-$0.43
Beta
1.04
Shares outstanding
30.33M
No. of employees
942
News stories
From sources across the web
About Castle Biosciences Inc
CEO-
Employees942
Founded2007
HeadquartersFriendswood, Texas, United States
SectorHealth care provider
Websitecastlebiosciences.com
Analyst ratings
Based on 7 analysts giving stock ratings to CSTL in the past 3 months
Strong buy
Buy
7
Hold
0
Sell
0
12-month forecast
Based on 7 Wall Street analysts offering 12 month price targets for CSTL in the last 3 months.
Highest
Current $23.95
$52.00 (+117.12%)
Average
$42.43 (+77.16%)
Lowest
$35.00 (+46.14%)
Analyst
Recommendation
Action
Price target
Projected
Date
Max Masucci
Roth MKM
Buy
Initiated
$40.00
+67%
06/25/2026
Unknown Analyst
Roth MKM
Buy
Initiated
$40.00
+67%
06/24/2026
Paul Knight
KeyBanc
Buy
Maintained
$35.00
+46.1%
05/29/2026
Mark Massaro
BTIG
Buy
Reiterated
$40.00
+67%
05/13/2026
Catherine Ramsey Schulte
Robert W. Baird
Buy
Maintained
$43.00
+79.5%
05/07/2026
Kyle Mikson CFA
Canaccord Genuity
Buy
Maintained
$40.00
+67%
05/06/2026
Thomas Flaten
Lake Street
Buy
Maintained
$52.00
+117.1%
05/07/2026
Subbu Nambi
Guggenheim
Buy
Maintained
$47.00
+96.2%
05/07/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
86.19M
83.04M
87.01M
83.68M
Cost of goods sold
17.63M
18.70M
18.32M
20.53M
Cost of revenue
17.63M
18.70M
18.32M
20.53M
Research and development expenses
12.79M
12.96M
13.52M
14.43M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
58.06M
55.91M
56.73M
64.90M
Operating expense
72.81M
71.14M
72.52M
81.55M
Total operating expenses
90.44M
89.85M
90.84M
102.09M
Operating income
-4.25M
-6.80M
-3.83M
-18.41M
Other non operating income
-
48.00K
-48.00K
-439.00K
EBT including unusual items
-143.00K
-386.00K
-2.71M
-14.41M
EBT excluding unusual items
-1.33M
-3.95M
-859.00K
-16.44M
Income tax expense
-4.67M
115.00K
-382.00K
109.00K
Effective tax rate
3,262.94%
-29.79%
14.08%
-0.76%
Other operating expenses
-
-
-
-
Net income
4.52M
-501.00K
-2.33M
-14.52M
Net profit margin
5.25%
-0.60%
-2.68%
-17.35%
Earnings per share
0.15
-0.02
-0.08
-0.49
Interest and investment income
2.94M
2.83M
2.90M
2.54M
Interest expense
-21.00K
-24.00K
-24.00K
-134.00K
Net interest expenses
2.92M
2.81M
2.87M
2.41M
Depreciation and amortization charges
-
-
-
-
EBITDA
-837.00K
-1.17M
-50.00K
-14.48M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
Give me an overview of CSTL
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer